<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04693208</url>
  </required_header>
  <id_info>
    <org_study_id>RC 02/2020</org_study_id>
    <nct_id>NCT04693208</nct_id>
  </id_info>
  <brief_title>Analgesic Effect of Laser Therapy in Children</brief_title>
  <official_title>Analgesic Effect of Laser Therapy in Paediatric Patients Undergoing Tonsillectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Burlo Garofolo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Burlo Garofolo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pain management after tonsillectomy could be challenging, with different protocols and&#xD;
      various outcome depending on individual patient; moreover, odynophagia due to surgery can, in&#xD;
      extreme cases, lead to block oral fluid intake, ending in dehydration and thus&#xD;
      hospitalization. A small pilot study demonstrated efficacy of photo-biomodulation (PBM) in&#xD;
      managing pain after tonsillectomy and it suggests that PBM can be included in clinical&#xD;
      practice. The present research aims to confirm and expand the findings from this study, being&#xD;
      the first step in including PBM in clinical routine after tonsillectomy. Use of this&#xD;
      treatment, which is non-damaging, non-toxic and easy to supply to patients, could greatly&#xD;
      improve individual quality of life after a surgical treatment; its use in the clinical&#xD;
      practice could represent an advantage for the institute, leading to more patients'&#xD;
      satisfaction, due to the lower pain sensation after surgery and quicker recovery time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 11, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in pain score, age 3-7 years</measure>
    <time_frame>After 24 hours</time_frame>
    <description>The score is evaluated using the Wong-Baker scale, ranged 0-10. Higher scores correspond to higher levels of pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in pain score, age 8-18 years</measure>
    <time_frame>After 24 hours</time_frame>
    <description>The score is evaluated using a Visual Analogue Scale (VAS) ranged 0-10. Higher scores correspond to higher levels of pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in pain score, age 3-7 years</measure>
    <time_frame>After 4 hours</time_frame>
    <description>The score is evaluated using the Wong-Baker scale, ranged 0-10. Higher scores correspond to higher levels of pain.depending on age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in pain score, age 3-7 years</measure>
    <time_frame>After 6 hours</time_frame>
    <description>The score is evaluated using the Wong-Baker scale, ranged 0-10. Higher scores correspond to higher levels of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in pain score, age 8-18 years</measure>
    <time_frame>After 4 hours</time_frame>
    <description>The score is evaluated using a Visual Analogue Scale (VAS) ranged 0-10. Higher scores correspond to higher levels of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in pain score, age 8-18 years</measure>
    <time_frame>After 6 hours</time_frame>
    <description>The score is evaluated using a Visual Analogue Scale (VAS) ranged 0-10. Higher scores correspond to higher levels of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of use of pain killer drugs</measure>
    <time_frame>Within 24 hours</time_frame>
    <description>Number of postoperative pain killers drugs administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in pain score evaluated by parents</measure>
    <time_frame>7 days after discharge</time_frame>
    <description>Pain evaluated by parents using a Visual Analogue Scale (VAS) ranged 0-10. Higher scores correspond to higher levels of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of sleep</measure>
    <time_frame>7 days after discharge</time_frame>
    <description>The quality of children sleep will be evaluated by parents or caregivers through a questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean daily food intake.</measure>
    <time_frame>7 days after discharge</time_frame>
    <description>The mean daily food intake of children will be evaluated by parents or caregivers through a questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of use of pain killer drugs</measure>
    <time_frame>7 days after discharge</time_frame>
    <description>The number of pain killers drugs administered at home will be measured by parents or caregivers.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laser light will be applied to the surgery site after tonsils excision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser therapy</intervention_name>
    <description>Laser treatment parameters will be two combined wavelength (660 and 970 nm), 3.2 Watt peak power, 320 milliWatt/cm2, 36.8 Joule/cm2 fluency, and 50% frequency, for a total time of 3 minutes for each site</description>
    <arm_group_label>Laser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Tonsillectomy or adenotonsillectomy due to apneic chronic snoring and/or obstructive sleep&#xD;
        apnea and/or recurrent tonsillitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. American Society of Anesthesiologists (ASA) Score &gt; 2&#xD;
&#xD;
          2. Neuropsychiatric co-morbidity&#xD;
&#xD;
          3. Pro-hemorrhage coagulation disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raffaella Sagredini, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute for maternal and child health IRCCS Burlo Garofolo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva Orzan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for maternal and child health IRCCS Burlo Garofolo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raffaella Sagredini, MD</last_name>
    <phone>00390403785111</phone>
    <email>raffaella.sagredini@burlo.trieste.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paola Staffa, MD</last_name>
    <phone>00390403785111</phone>
    <email>paola.staffa@burlo.trieste.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute for Maternal and Child Health - IRCCS Burlo Garofolo-</name>
      <address>
        <city>Trieste</city>
        <zip>34137</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raffaella Sagredini, MD</last_name>
      <email>raffaelle.sagredini@burlo.trieste.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 31, 2020</study_first_submitted>
  <study_first_submitted_qc>December 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Tonsillectomy</keyword>
  <keyword>Laser Therapy</keyword>
  <keyword>Photo-biomodulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

